keyword
https://read.qxmd.com/read/38470999/uveitic-flare-ups-after-gonioscopy-assisted-transluminal-trabeculotomy-gatt-in-patients-with-uveitic-glaucoma
#1
JOURNAL ARTICLE
Raz Gepstein, Tamar Laytman Klein, Liron Naftali Ben Haim, Avner Belkin
PURPOSE: To assess the risk of gonioscopy-assisted transluminal trabeculotomy (GATT) inducing an uveitic flare-up in patients with uveitic glaucoma (UG). METHODS: This retrospective study included consecutive UG patients who underwent GATT at a single medical center between June 2020 and September 2022. The main outcome measure was the occurrence of a surgery-related uveitic complication defined as either an uveitic flare-up defined by the Standardization of Uveitis Nomenclature (SUN) criteria, or the appearance of cystoid macular edema (CME) from 2 weeks to 3 months after surgery...
March 12, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38372515/clinical-and-therapeutic-characteristics-of-childhood-uveitis-in-a-tertiary-center-in-tunisia
#2
JOURNAL ARTICLE
Salma Gargouri, Kmar Maaloul, Imene Kaibi, Mona Rekik, Hajer Aloulou, Amira Trigui
INTRODUCTION: Childhood uveitis is a rare condition with various associated diagnostic and therapeutic challenges. AIM: We proposed to describe the distribution, clinical findings, treatment, complications, and visual outcomes of uveitis in children at a tertiary referral center in Sfax, Tunisia. METHODS: A retrospective study of 33 children (54 eyes) with uveitis collected over the period from January 2009 to December 2018 was carried out at the Ophthalmology Department of Habib Bourguiba University Hospital, Sfax, Tunisia...
May 5, 2023: La Tunisie Médicale
https://read.qxmd.com/read/38296910/risk-factors-for-failing-sub-tenon-s-triamcinolone-acetonide-for-uveitic-macular-edema
#3
JOURNAL ARTICLE
Amit K Reddy, Jennifer L Patnaik, Alan G Palestine
BACKGROUND: Sub-Tenon's triamcinolone acetonide (STA) is less effective than intravitreal corticosteroids in the treatment of uveitic macular edema (ME), but does have some relative advantages, including substantially lower cost and decreased risk of post-injection ocular hypertension. It would be useful for clinicians to know which eyes may respond well to STA and not necessarily require intravitreal therapy. The objective of this study is to identify risk factors for failing STA for the treatment of uveitic ME...
February 1, 2024: Journal of Ophthalmic Inflammation and Infection
https://read.qxmd.com/read/38251704/automatic-identification-and-severity-classification-of-retinal-biomarkers-in-sd-oct-using-dilated-depthwise-separable-convolution-resnet-with-svm-classifier
#4
JOURNAL ARTICLE
Adithiya S V, Dharani Bai G, Rajiv Raman
PURPOSE: Diagnosis of Uveitic Macular Edema (UME) using Spectral Domain OCT (SD-OCT) is a promising method for early detection and monitoring of sight-threatening visual impairment. Viewing multiple B-scans and identifying biomarkers is challenging and time-consuming for clinical practitioners. To overcome these challenges, this paper proposes an image classification hybrid framework for predicting the presence of biomarkers such as intraretinal cysts (IRC), hyperreflective foci (HRF), hard exudates (HE) and neurosensory detachment (NSD) in OCT B-scans along with their severity...
January 22, 2024: Current Eye Research
https://read.qxmd.com/read/38194432/safety-and-efficacy-of-cls-ta-by-anatomic-location-of-inflammation-results-from-the-phase-3-peachtree-clinical-trial
#5
JOURNAL ARTICLE
Milan Shah, Thomas Albini, Quan Nguyen, Charles Wykoff, Mark Barakat, Rahul Khurana, Barry Kapik, Thomas A Ciulla
PURPOSE: To explore the efficacy of CLS-TA, a proprietary suprachoroidal injectable suspension of triamcinolone acetonide, in noninfectious uveitis (NIU) with macular edema (ME), categorized by anatomic subtype. METHODS: Patients diagnosed with ME associated with NIU of any etiology and anatomic subtype were eligible for the phase 3 PEACHTREE trial of CLS-TA. Post-hoc analyses were performed, stratified by discrete anatomic subtype of uveitis (anterior, intermediate, posterior, and panuveitis...
January 9, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38133948/demographic-and-clinical-characteristics-of-uveitis-for-adult-patients-attending-mansoura-ophthalmic-center
#6
JOURNAL ARTICLE
Eman E Ahmed, Eglal M El Saeid, Hanem M Kishk, Anas Adi, Amgad El Nokrashy
AIM: The aim of this research is to evaluate the demographic attributes and clinical manifestations of uveitis in adult patients frequenting the Mansoura Ophthalmic Center. METHODS: Utilizing a cross-sectional, prospective, analytical study design, this research engaged adult patients visiting the outpatient uveitis clinic at the Mansoura Ophthalmic Center. Comprehensive case evaluations involved collecting detailed patient histories, examining ophthalmic records, and conducting thorough ocular examinations...
December 22, 2023: Ocular Immunology and Inflammation
https://read.qxmd.com/read/37933173/non-steroidal-intravitreal-injection-for-noninfectious-uveitic-cystoid-macular-edema-systematic-review-and-meta-analysis
#7
REVIEW
Farzan Kianersi, Abdolreza Rezaeian-Ramsheh, Alireza Rahimi, Mohammadreza Akhlaghi, Alireza Dehghani, Ziba Farajzadegan, Mohsen Pourazizi
PURPOSE: To systematically review the published manuscripts on the non-steroidal intravitreal injection for treatment of noninfectious uveitic cystoid macular edema (CME). METHODS: The PubMed, Scopus, and Web of Science, Science Direct, ProQuest, Cochrane Library, ProQuest, Embase, Clinical Key, and Springer were searched for relevant articles published until May 2022. The random-effects models were used to estimate the mean difference (MD) and 95% confidence interval (CI) for postoperative central macular thickness (CMT) and visual acuity (VA) changes...
November 6, 2023: European Journal of Ophthalmology
https://read.qxmd.com/read/37917790/efficacy-of-pegylated-interferon-alpha-2a-in-uveitic-macular-edema-refractory-to-biologic-agents
#8
JOURNAL ARTICLE
Mohammad Avarand, Mine Esen Baris, Leila Taheri, Suzan Guven Yılmaz
PURPOSE: To report the efficacy of pegylated interferon alpha-2a (Roferon, Hoffmann-La Roche brands, Switzerland) in uveitic macular edema refractory to biologic agents. METHODS: Herein, we present two cases of non-infectious uveitis with cystoid macular edema (CME) who were unresponsive to immunosuppressant treatment, and whose uveitis and macular edema recurrences were prevented with subcutaneous injections of pegylated interferon α-2a. RESULTS: Two young males (27- and 30-year-old) diagnosed with non-infectious uveitis and CME were on immunosuppressive treatment...
November 2, 2023: Ocular Immunology and Inflammation
https://read.qxmd.com/read/37893595/early-and-late-complications-after-cataract-surgery-in-patients-with-uveitis
#9
JOURNAL ARTICLE
Gentian Bajraktari, Tomislav Jukić, Miro Kalauz, Martin Oroz, Andrea Radolović Bertetić, Nenad Vukojević
Background and Objectives : Uveitis, a prevalent eye disorder characterized by inflammatory processes, often leads to cataract formation and significant visual impairment. This study aimed to evaluate preoperative conditions and postoperative outcomes following cataract surgery in uveitis patients. Materials and Methods : A retrospective study was conducted at the University Hospital Center Rebro Zagreb, Croatia, involving uveitis patients who underwent cataract surgery between 2013 and 2022. Eligible patients had uveitic cataracts affecting visual acuity or posterior segment visualization in a "quiet eye" and were disease-inactive for at least three months...
October 23, 2023: Medicina
https://read.qxmd.com/read/37721556/efficacy-of-intravitreal-dexamethasone-implant-used-as-monotherapy-for-the-treatment-of-macular-edema-in-non-infectious-uveitis-a-retrospective-analysis
#10
JOURNAL ARTICLE
Rishi B Gupta, Julius Ilin, Chloe C Gottlieb
BACKGROUND: Uveitic macular edema is a complication of acute or chronic uveitis. Current treatment regiments frequently have numerous side effects, often requiring supplemental treatment. This study investigates the efficacy of dexamethasone (DEX) intravitreal implants as monotherapy for treatment of macular edema in non-infectious intermediate, posterior or panuveitis. METHODS AND RESULTS: Retrospective chart review of thirty patients with intermediate, posterior and panuveitis treated with DEX...
September 18, 2023: Journal of Ophthalmic Inflammation and Infection
https://read.qxmd.com/read/37560325/dexamethasone-intravitreal-implant-for-macular-edema-and-some-other-rare-indications-in-uveitis
#11
JOURNAL ARTICLE
Seher Koksaldi, Mustafa Kayabaşi, Zıya Ayhan, Mahmut Kaya, Taylan Öztürk, Aylın Yaman, Ali Osman Saatci
In the present study, 110 eyes of 81 patients with uveitis who underwent intravitreal dexamethasone implant (IDI) injection and had a follow-up of at least 6 months between January, 2012 and September, 2022, were retrospectively analyzed. A total of 298 IDI injections were administered (mean, 2.71±2.37; range, 1-12). The mean age of the patients was 49.44±16.67 years (range, 15-86 years). The mean follow-up time after the first IDI was 34.31±26.53 months (range, 6-115 months). In total, 77 (95...
2023: Med Int (Lond)
https://read.qxmd.com/read/37494198/the-large-hellenic-study-of-uveitis-diagnostic-and-therapeutic-algorithms-complications-and-final-outcome
#12
JOURNAL ARTICLE
Dimitrios Kalogeropoulos, Ioannis Asproudis, Maria Stefaniotou, Marilita M Moschos, Vassilios P Kozobolis, Paraskevi V Voulgari, Andreas Katsanos, Constantina Gartzonika, Chris Kalogeropoulos
PURPOSE: The purpose of this study is to present the diagnostic and therapeutic algorithms, complications, and final outcome in the management of uveitic patients at a tertiary academic referral center. DESIGN: Observational study. METHODS: Analysis of the archives of 6191 uveitic patients at the Ocular Inflammation Service of the Department of Ophthalmology of the University Hospital of Ioannina in Greece from 1991 to 2020. RESULTS: During the 30 years of the study, the diagnostic ability climbed from 45...
January 2023: Asia-Pacific Journal of Ophthalmology
https://read.qxmd.com/read/37440091/frequency-and-treatment-regimens-of-macular-edema-in-1946-consecutive-patients-with-noninfectious-uveitis-at-a-tertiary-ophthalmic-center-in-shaanxi-china
#13
JOURNAL ARTICLE
Yan-Qi Xue, Jin-An Xiao, Ying Chen
INTRODUCTION: We investigated the frequency of uveitic macular edema (UME) in patients with different types of noninfectious uveitis and present the primary treatment methods for UME at a specialized eye center in Shaanxi Province, China. METHODS: We conducted a retrospective, noninterventional, observational survey involving 1946 patients with noninfectious uveitis (2816 eyes). The collected data included sex, age of uveitis onset, age of UME onset, anatomical classification of uveitis, and the treatment administered to UME patients...
July 13, 2023: Ophthalmology and Therapy
https://read.qxmd.com/read/37432451/incidence-and-treatment-approach-of-intraocular-pressure-elevation-after-various-types-of-local-steroids-for-retinal-diseases
#14
JOURNAL ARTICLE
Agata Anna Wykrota, Alaa Din Abdin, Cristian Munteanu, Ursula Löw, Berthold Seitz
PURPOSE: For the treatment of macular edema, in addition to the use of antivascular endothelial growth factors, steroids are also used intravitreally and sub-Tenon. Side effects include among others cataract formation and elevation of intraocular pressure (IOP). The aim of this retrospective study was to elicit the IOP elevation after administration of various steroidal medication, the time of onset, and the efficacy of the administered IOP-lowering therapies. METHODS: We included 428 eyes with a postoperative (n = 136), diabetic (n = 148), uveitic macular edema (n = 61), and macular edema after retinal vein occlusion (n = 83)...
July 11, 2023: Graefe's Archive for Clinical and Experimental Ophthalmology
https://read.qxmd.com/read/37384926/functional-and-morphological-responses-to-fluocinolone-acetonide-0-19%C3%A2-mg-in-noninfectious-uveitic-macular-edema-evaluated-as-the-area-under-the-curve
#15
JOURNAL ARTICLE
Lucy Joanne Kessler, Gerd Uwe Auffarth, Ramin Khoramnia
Purpose: This study investigated the impact of baseline clinical and optical coherence tomography (OCT) factors on the response to a 0.19-mg fluocinolone acetonide (FAc) implant in patients with noninfectious uveitic macular edema evaluated by the area under the curve over 24 months. Methods: A retrospective study was conducted of eyes of patients with noninfectious uveitic macular edema undergoing FAc treatment, with follow-up from baseline to 24 months. The area under the curve (AUC) of best-corrected visual acuity (BCVA) and the central macular thickness (CMT) were calculated using the trapezoidal rule...
June 29, 2023: Journal of Ocular Pharmacology and Therapeutics
https://read.qxmd.com/read/37379111/-bilateral-uveitis-associated-with-protein-kinase-inhibitor-based-treatment-of-skin-melanoma-case-study
#16
JOURNAL ARTICLE
E V Udovichenko, L P Danilova, E L Sorokin, A A Fil
The article presents a clinical case of bilateral uveitis with macular edema that developed during long-term administration of vemurafenib. Methods of conservative treatment of malignant tumors are presently available and reasonably effective. However, at the same time drugs can have toxic effect on normal cells in various tissues of the body. According to our data, the use of corticosteroids can ameliorate the clinical signs of macular edema associated with uveitis, but with a tendency to recur. Only complete cancellation of vemurafenib provided remission of sufficient duration, which is fully consistent with clinical observations made by colleagues...
2023: Vestnik Oftalmologii
https://read.qxmd.com/read/37357450/an-overview-of-pediatric-uveitis
#17
JOURNAL ARTICLE
İlknur Tuğal-Tutkun
Uveitis in childhood poses a distinct challenge, mainly because of the insidious onset and chronic course of intraocular inflammation in most cases, which may result in permanent visual loss due to delayed diagnosis and treatment. Although anterior uveitis, frequently associated with juvenile idiopathic arthritis, is the most common form of ocular involvement, idiopathic intermediate uveitis (pars planitis) is also a common uveitic entity in childhood. Posterior or panuveitis of a variety of noninfectious or infectious etiologies may be seen as well...
July 2023: Turkish archives of pediatrics
https://read.qxmd.com/read/37318415/intravitreal-therapy-for-uveitic-macular-edema-ranibizumab-versus-methotrexate-versus-the-dexamethasone-implant-the-merit-trial-results
#18
RANDOMIZED CONTROLLED TRIAL
Nisha R Acharya, Albert T Vitale, Elizabeth A Sugar, Janet T Holbrook, Alyce E Burke, Jennifer E Thorne, Michael M Altaweel, John H Kempen, Douglas A Jabs
PURPOSE: To evaluate the effectiveness of 3 different intravitreal treatments for persistent or recurrent uveitic macular edema (ME): dexamethasone implant, methotrexate, and ranibizumab. DESIGN: Single-masked, randomized controlled clinical trial. PARTICIPANTS: Patients with minimally active or inactive uveitis and persistent or recurrent uveitic ME in one or both eyes. METHODS: Patients at 33 centers were randomized 1:1:1 to receive 1 of the 3 therapies...
September 2023: Ophthalmology
https://read.qxmd.com/read/37227553/combined-central-retinal-vein-occlusion-and-cilioretinal-artery-occlusion-as-the-initial-presentation-of-frosted-branch-angiitis-a-case-report-and-literature-review
#19
JOURNAL ARTICLE
Abdullah Albahlal, Waleed Khayyat, Sulaiman M Alsulaiman
PURPOSE: To report a case of combined central retinal vein occlusion (CRVO) with cilioretinal artery occlusion (CLRAO) that heralded the development of frosted branch angiitis (FBA). CASE REPORT: A 25-year-old healthy male presented with sudden painless visual loss in his left eye with a visual acuity (VA) of 20/300. Fundus exam and fluorescein angiography showed signs of combined CRVO and CLRAO. Without treatment, his vision gradually improved until it reached 20/30 within four months...
May 25, 2023: Journal of Ophthalmic Inflammation and Infection
https://read.qxmd.com/read/37166627/efficacy-and-safety-of-adalimumab-in-pediatric-non-infectious-non-anterior-uveitis-real-life-experience-from-the-international-aida-network-uveitis-registry
#20
JOURNAL ARTICLE
Antonio Vitale, Francesca Della Casa, Silvana Guerriero, Gaafar Ragab, Angela Mauro, Valeria Caggiano, Marco Cattalini, Emanuela Del Giudice, Rossella Favale, Carla Gaggiano, Irene Bellicini, Maria Pia Paroli, Mohamed Tharwat Hegazy, Jurgen Sota, Abdurrahman Tufan, Alberto Balistreri, Ibrahim Almaghlouth, Francesco La Torre, Ewa Więsik-Szewczyk, Maria Tarsia, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, Bruno Frediani, Gian Marco Tosi, Alex Fonollosa, José Hernández-Rodríguez, Rana Hussein Amin, Giuseppe Lopalco, Donato Rigante, Luca Cantarini, Claudia Fabiani
INTRODUCTION: Scientific evidence of the effectiveness of the tumor necrosis factor inhibitor adalimumab (ADA) in pediatric patients with non-infectious non-anterior uveitis is still limited. The aim of this study is to investigate the therapeutic role of ADA in a cohort of pediatric patients with non-anterior uveitis. METHODS: This is an international multicenter study analyzing real-life data referred to pediatric patients treated with ADA for intermediate uveitis/pars planitis, posterior uveitis and panuveitis...
August 2023: Ophthalmology and Therapy
keyword
keyword
52850
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.